Board Stats

Exelixis Inc

Y! EXEL chart/quote @ Y! F #EXEL @ Stocktwits $EXEL stream @ Twitter @ExelixisInc (Company Twitter Account) EXEL Facebook Page EXEL @ LinkedIn

EXEL / Message Board

BOARD

GROUPS

Written By On Topic Only -- All Messages

Hide Replies

Keyword
Subject

Between			and
Rec'd By

Authored By
Minimum Recs

MSG #	SUBJECT	TYPE	AUTHOR	SENTIMENT	RECS	DATE POSTED
28124	Building IP: EXEL Patent Grant re "Method of treating renal cell carcinoma using N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N'-(4-fluorophenyl)cyclopropa- ne-1,1-dicarboxamide, (2S)-hydroxybutanedioate	GN	JBWIN		4	10/19/2021 5:58:43 PM

28123	Two weeks — 11/2/2021 Earnings Report	GN	TaiTienMuyBien		0	10/19/2021 4:41:51 PM

28122	Re: TKI Total and New Rx including Cabo	GN	commonwealthinc		5	10/15/2021 7:17:26 PM

28121	Re: TKI Total and New Rx including Cabo	GN	TaiTienMuyBien		3	10/15/2021 5:57:29 PM

28120	Astrazeneca’s Himalaya study is a surprising hit in first-line liver cancer, but competition is already present.	GN	Pacific		1	10/15/2021 4:51:48 PM

28119	Re: TKI Total and New Rx including Cabo	GN	JBWIN		10	10/15/2021 4:05:04 PM

28118	Re: TKI Total and New Rx including Cabo	GN	JBWIN		7	10/15/2021 3:57:11 PM

28117	Re: TKI Total and New Rx including Cabo	GN	TaiTienMuyBien		1	10/15/2021 3:35:58 PM

28116	TKI Total and New Rx including Cabo	GN	JBWIN		7	10/15/2021 12:27:46 PM

28115	Re: HCW - EXEL: Exelixis Strikes STORM Partnership and In-Licenses XL114 from Aurigene	GN	duckduffer	Strong Buy	5	10/14/2021 4:36:57 PM

Go to Msg #

BOARDS Sign In for Filters